Old CIC Events

Evolutionary dynamics of human cancers
Trevor Graham — Cancer Research UK Barts Centre / Queen Mary University of London

Targeting RAS-PI3K signaling to re-educate the stroma of RAS mutant lung cancers
Esther Castellano — Centro de Investigación del Cáncer, CIC-IBMCC

Role of RRAS2 as an oncogenic driver
Laura Clavaín — Centro de Investigación del Cáncer (CIC-IBMCC)

Control of Actin Polymerization in Cells Through Activation and Inhibition of the Arp2/3 Complex
Roberto Domínguez — Department of Physiology. University of Pennsylvania. Perelman School of Medicine (Philadelphia, USA)

Role of cytosine-5 methylation of ribosomal RNA in cell cycle control
Judith López Luis — Centro de Investigación del Cáncer (CIC-IBMCC)

Addressing the true complexity of biology with 10x Genomics single cell and spatial multiomics
Luca Mazzitelli , 10x Genomics — 10x Genomics

Novel mechanisms controlling KRAS oncogenic output: impact on tumour fitness and cancer vulnerabilities
David Santamaría — University of Bordeaux, France

VRK1-mediated regulation of Tip60/KAT5 acetyltransferase during DDR
Raúl García — Centro de Investigación del Cáncer (CIC-IBMCC)

Receptor nanoclustering modulates chemokine responses
Mario Mellado Alonso — Centro Nacional de Biotecnología (CNB)

Mechanisms of KRAS signaling in lung cancer development
Dr. Matthias Drosten — Centro Nacional de Investigaciones Oncológicas CNIO

Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism and redox homeostasis
Rósula García Navas — Centro de Investigación del Cáncer (CIC-IBMCC)